Provided by Tiger Trade Technology Pte. Ltd.

INVESCO PHARMACEUTICALS ETF

130.98
+0.95270.73%
Post-market: 130.990.0042+0.00%19:30 EDT
Volume:8K
Turnover:1.10M
Market Cap:537.03M
PE:6.79
High:131.13
Open:130.41
Low:130.38
Close:130.03
52wk High:131.68
52wk Low:90.01
Shares:4.10M
Float Shares:4.10M
Volume Ratio:0.40
T/O Rate:0.20%
Dividend:1.06
Dividend Rate:0.81%
EPS(TTM):19.29
EPS(LYR):21.73
ROE:23.89%
ROA:0.60%
PB:1.61
PE(LYR):6.03

Loading ...

Eli Lilly (LLY) Stock Looks Undervalued Relative To Fair Value

Simply Wall St.
·
Aug 19

Johnson & Johnson on Pace for Record High Close

Dow Jones
·
Aug 19

JNJ-Backed Lung Biopsy Scanner Study Signals New Edge in Cancer Diagnostics

TIPRANKS
·
Aug 19

Johnson & Johnson Stock (JNJ) Moved Up by 3.28% on Aug 18: A Full Analysis

TradingKey
·
Aug 19

AbbVie Sets Q3 2026 Distribution at R$ 0.38 Per Unit, Payable Aug. 20

Reuters
·
Aug 18

Johnson & Johnson Report Flags Rise of “surgical Intelligence” as Next Digital Surgery Inflection Point

Reuters
·
Aug 18

Trump's Privateer Hacking Plan Brings High Risk to Companies Taking Part

Dow Jones
·
Aug 18

Eli Lilly Pays $10 Million Upfront to AlzeCure Under Alzstatin Deal

MT Newswires Live
·
Aug 18

Lytix Biopharma Names Timothy Herpin Chief Business Officer

Reuters
·
Aug 18

Basilea Publishes Investor Presentation on Anti-Infectives Strategy and Pipeline Progress

Reuters
·
Aug 18

Perrigo Co. PLC Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Aug 18

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 18

Sector Update: Healthcare

MT Newswires Live
·
Aug 18

Top Midday Gainers

MT Newswires Live
·
Aug 18

Eli Lilly Canada: Disagrees with Characterizations in Canada Revenue Agency’s Application; Will Respond Formally Through Court Process in Due Course

THOMSON REUTERS
·
Aug 17

Eli Lilly Canada: Continues to Take Action to Address Promotion and Sale of Unapproved and Illegal Retatrutide Products in Canada

THOMSON REUTERS
·
Aug 17

PRESS Digest-Canada - August 17

Reuters
·
Aug 17

Leal Therapeutics: Raises $30M in Series a Extension Financing, Adds Eli Lilly as New Investor

THOMSON REUTERS
·
Aug 17

Eli Lily Initiates New Phase Iii Clinical Trials for Adult Depression Treatment Brenipatide in China - Notice

THOMSON REUTERS
·
Aug 17

Eli Lily Initiates New Phase III Clinical Trials for Brenipatide in China

Reuters
·
Aug 17